Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions

Intensive Care Medicine

Volumn 38, Issue 8, 2012, Pages 1315-1325

  León, Cristóbal ^a   Ruiz Santana, Sergio ^b   Saavedra, Pedro ^c   Castro, Carmen ^a   Úbeda, Alejandro ^a   Loza, Ana ^a   Martín Mazuelos, Estrella ^a   Blanco, Armando ^d   Jerez, Vicente ^e   Ballús, Josep ^f   Álvarez Rocha, Luis ^g   Utande Vázquez, Aránzazu ^h   Fariñas, Osvaldo ^b  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL INFANTA CRISTINA   (Spain)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^g HOSPITAL JUAN CANALEJO   (Spain)

^h HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

(1 3) D Glucan; Abdominal conditions; C reactive protein; Candida albicans germ tube antibody (CAGTA); Critically ill patients; Procalcitonin

Indexed keywords

1,3 BETA GLUCANASE; C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; ARTICLE; CANDIDA ALBICANS; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FUNGAL COLONIZATION; HUMAN; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; ANTIBODIES, FUNGAL; BETA-GLUCANS; C-REACTIVE PROTEIN; CALCITONIN; CANDIDA ALBICANS; CANDIDEMIA; DECISION TREES; DIGESTIVE SYSTEM DISEASES; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84864281563     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2616-y     Document Type: Article

References (31)

1. Eggimann P, Bille J, Marchetti O (2011) Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care 1:37. doi:10.1186/2110-5820-1-37
2. León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, León MA (2006) A bedside scoring system ("Candida score") for early antifungal treatment in non-neutropenic critically ill patients with Candida colonization. Crit Care Med 34:730-737
3. Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH (2007) Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 26:271-276 (Pubitemid 46572022)
4. León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, Balasini C, Utande-Vázquez A, González de Molina FJ, Blasco-Navalproto MA, López MJ, Charles PE, Martín E, Hernández-Viera MA (2009) Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624-1633
5. Kratzer C, Graninger W, Lassnigg A, Presterl E (2011) Design and use of Candida scores at the intensive care unit. Mycoses 54:467-474
6. Koo S, Bryar JM, Page JH, Baden LR, Marty FM (2009) Diagnostic performance of the (1?3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis 49:1650-1659
7. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME (2011) b-D-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 52:750-770
8. Moragues MD, Ortiz N, Iruretagoyena JR, García-Ruiz JC, Amutio E, Rojas A, Mendoza J, Quindós G, Pontón-San Emeterio J (2004) Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis. Enferm Infecc Microbiol Clin 22:83-88 (Pubitemid 38585446)
9. Zaragoza R, Pemán J, Quindós G, Iruretagoyena JR, Cuétara MS, Ramírez P, Gómez MD, Camarena JJ, Viudes A, Pontón J (2009) Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients. Clin Microbiol Infect 15:592-595
10. Pemán J, Zaragoza R, Quindós R, Alkorta M, Cuétara MS, Camarena JJ, Ramírez P, Giménez MJ, Martín-Mazuelos E, Linares-Sicilia MJ, Pontón J (2011) Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients. BMC Infect Dis 11:60. doi: 10.1186/1471-2334-11-60
11. Povoa PR, Teixeira-Pinto AM, Carneiro AH (2011) C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Crit Care 15:R169
12. Charles PE, Castro C, Ruiz-Santana S, León C, Saavedra P, Martín E (2009) Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Intensive Care Med 35:2146-2150
13. Schuetz P, Albrich W, Mueller B (2011) Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 9:107. doi: 10.1186/1741-7015-9-107
14. Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, Chavanet P, Blettery B (2005) Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med 31:393-400
15. León C, Alvarez-Lerma F, Ruiz-Santana S, León MA, Nolla J, Jordá R, Saavedra P, Palomar M (2009) Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis 28:233-242
16. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813-1822
17. Blot SI, Vandewoude KH, De Waele JJ (2007) Candida peritonitis. Curr Opin Crit Care 13:195-199 (Pubitemid 46328335)
18. Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Schlamm HT, Oborska IT, Rex JH, Kullberg BJ (2011) Ocular manifestations of candidemia. Clin Infect Dis 53:262-268
19. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, óGrady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1-45
20. Breiman L, Freidman JH, Olshen RA, Stone CJ (1984) Classification and regression trees. Wadsworth, Belmont
21. Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10:882-885 (Pubitemid 37129504)
22. Takesue Y, Kakehashi M, Ohge H, Imamura Y, Murakami Y, Sasaki M, Morifuji M, Yokoyama Y, Kouyama M, Yokoyama T, Sueda T (2004) Combined assessment of beta-D-glucan and degree of Candida colonization before starting empiric therapy for candidiasis in surgical patients. World J Surg 28:625-630 (Pubitemid 38802803)
23. Acosta J, Catalan M, Del Palacio-Peréz-Medel A, Lora D, Montejo JC, Cuetara MS, Moragues MD, Ponton J, del Palacio A (2011) A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1?3)-b-D-glucan chromogenic assay in serum samples. Clin Microbiol Infect 17:1053-1060
24. Posteraro B, De Pascale G, Tumbarello M, Torelli R, Pennisi MA, Bello G, Maviglia R, Fadda G, Sanguinetti M, Antonelli M (2011) Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1?3)-beta-D-glucan assay, Candida score, and colonization index. Crit Care 15:R249. doi: 10.1186/cc10507
25. Mohr JF, Sims Ch, Paetznick V, Rodriguez J, Finkelman MA, Rex JH, Ostrosky-Zeichner L (2011) A prospective survey of (1-3)-b-D-glucan and its relationship to invasive candidiasis in the surgical ICU setting. J Clin Microbiol 49:58-61
26. Onishi A, Sugiyama D, Kogata Y, Saegusa J, Sugimoto T, Kawano S, Morinobu A, Nishimura K, Kumagai S (2012) Diagnostic accuracy of serum 1,3-b-D-glucan for Pneumocystis jirovecii pneumonia, invasive candidiasis and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 50:7-15
27. Albert O, Toubas D, Strady C, Cousson J, Delmas C, Vernet V, Villena I (2011) Reactivity of (1?3)-b-D-glucan assay in bacterial bloodstream infections. Eur J Clin Microbiol Infect 30:1453-1460
28. Metan G, Agkus C, Nedret Koc A, Elmali F, Finkelman MA (2011) Does ampicillin-sulbactam cause false positivity of (1,3)-beta-D-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections. Mycoses. doi: 10.1111/j.1439-0507.2011.02131.x
29. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL (2005) Evaluation of a (1?3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43:5957-5962 (Pubitemid 43100644)
30. Presterl E, Parschalk B, Bauer E, Lassnigg A, Hajdu S, Graninger W (2009) Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients. Int J Infect Dis 13:707-1712
31. Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, Shields RM, Cheng S, Mitsani D, Vadnerkar A, Silveira FP, Kleiboeker SB, Clancy CJ (2012) Performance of Candida real-time polymerase chain reaction, b-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 54:1240-1248